Alaunos Therapeutics (TCRT) Free Cash Flow (2016 - 2025)
Historic Free Cash Flow for Alaunos Therapeutics (TCRT) over the last 15 years, with Q3 2025 value amounting to -$844000.0.
- Alaunos Therapeutics' Free Cash Flow fell 806.66% to -$844000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.9 million, marking a year-over-year increase of 7527.2%. This contributed to the annual value of -$5.0 million for FY2024, which is 8361.51% up from last year.
- As of Q3 2025, Alaunos Therapeutics' Free Cash Flow stood at -$844000.0, which was down 806.66% from -$701000.0 recorded in Q2 2025.
- In the past 5 years, Alaunos Therapeutics' Free Cash Flow registered a high of -$592000.0 during Q4 2024, and its lowest value of -$23.3 million during Q2 2021.
- Over the past 5 years, Alaunos Therapeutics' median Free Cash Flow value was -$7.0 million (recorded in 2022), while the average stood at -$6.9 million.
- Its Free Cash Flow has fluctuated over the past 5 years, first tumbled by 4856.4% in 2021, then soared by 9198.38% in 2024.
- Quarter analysis of 5 years shows Alaunos Therapeutics' Free Cash Flow stood at -$15.5 million in 2021, then soared by 54.81% to -$7.0 million in 2022, then fell by 5.53% to -$7.4 million in 2023, then skyrocketed by 91.98% to -$592000.0 in 2024, then crashed by 42.57% to -$844000.0 in 2025.
- Its last three reported values are -$844000.0 in Q3 2025, -$701000.0 for Q2 2025, and -$772000.0 during Q1 2025.